MLchartDataset catalogue

polatuzumab vedotin

Term · Oncology and biomedicine · MLC-T-ONC-006782

A drug used with other drugs to treat adults with certain types of diffuse large B-cell lymphoma. It is also being studied in the treatment of other types of cancer. Polatuzumab vedotin contains a monoclonal antibody that binds to a protein called CD79B, which is found on B cells (a type of white blood cell) and some lymphoma cells. It also contains an anticancer drug, which may help kill cancer cells. Polatuzumab vedotin is a type of antibody-drug conjugate. Also called Polivy.

Table 1. Record
IdentifierMLC-T-ONC-006782
FieldOncology and biomedicine
SynonymsPolivy
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-006782",
  "term": "polatuzumab vedotin",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with other drugs to treat adults with certain types of diffuse large B-cell lymphoma. It is also being studied in the treatment of other types of cancer. Polatuzumab vedotin contains a monoclonal antibody that binds to a protein called CD79B, which is found on B cells (a type of white blood cell) and some lymphoma cells. It also contains an anticancer drug, which may help kill cancer cells. Polatuzumab vedotin is a type of antibody-drug conjugate. Also called Polivy.",
  "synonyms": [
    "Polivy"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/polatuzumab-vedotin/"
}

Record 13,409 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.